uniQure
Tom van der Zon has extensive experience in scientific and research roles, primarily at uniQure since August 2014, progressing from Junior Technician in Emerging Technologies to Scientific Associate in Capsid Development. Previous positions include roles at A.L.S.R.V. Asopos de Vliet as Commissaris and at MHIR as Surveillant. Tom van der Zon also gained research experience during internships at Leiden University Medical Center, focusing on Allergy and Pathology, and at HAL Allergy. Educationally, Tom van der Zon holds a Bachelor of Applied Science in Biology and Medical Laboratory Sciences with a specialization in Cytohistopathology from Hogeschool Leiden.
This person is not in any teams
This person is not in any offices
uniQure
2 followers
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. They are leveraging their modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.